191 related articles for article (PubMed ID: 2590998)
1. Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
Benjamin LA; McGarry RC; Hart DA
Cancer Chemother Pharmacol; 1989; 25(1):25-31. PubMed ID: 2590998
[TBL] [Abstract][Full Text] [Related]
2. Alterations in plasminogen activator and inhibitor activity during the differentiation of a human neuroblastoma cell line, SMS-KAN.
Benjamin LA; McGarry RC; Hart DA
Cancer Lett; 1989 Feb; 44(2):101-8. PubMed ID: 2537681
[TBL] [Abstract][Full Text] [Related]
3. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
Tienari J; Alanko T; Lehtonen E; Saksela O
Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
5. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.
Niiya K; Nsimba M; Hayashi T; Sakuragawa N
Thromb Res; 1992 Feb; 65(3):311-21. PubMed ID: 1631798
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
8. Characterization of plasminogen activator from two human renal carcinoma cell lines.
Nelson NF; Cieplak W; Dacus SC; Prager MD
J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro.
Karlan BY; Amin W; Band V; Zurawski VR; Littlefield BA
Gynecol Oncol; 1988 Sep; 31(1):103-12. PubMed ID: 3410341
[TBL] [Abstract][Full Text] [Related]
10. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.
Sitrin RG; Gyetko MR; Kole KL; McKeever P; Varani J
Cancer Res; 1990 Aug; 50(16):4957-61. PubMed ID: 2379161
[TBL] [Abstract][Full Text] [Related]
11. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.
Rao JS; Baker JB; Morantz RA; Kimler B; Evans R; Festoff BW
Cancer Res; 1990 Aug; 50(16):5039-44. PubMed ID: 2116223
[TBL] [Abstract][Full Text] [Related]
12. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
[TBL] [Abstract][Full Text] [Related]
14. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activators and their inhibitors in the neuromuscular system: I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines.
Festoff BW; Rao JS; Maben C; Hantaï D
J Cell Physiol; 1990 Aug; 144(2):262-71. PubMed ID: 2199466
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
Waghray A; Webber MM
Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
[TBL] [Abstract][Full Text] [Related]
18. The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1.
Sarubbi E; Nolli ML; Robbiati F; Soffientini A; Parenti F; Cassani G
Thromb Haemost; 1989 Nov; 62(3):927-33. PubMed ID: 2512681
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of urokinase and thrombin in cultured neural cells.
Wagner SL; Lau AL; Nguyen A; Mimuro J; Loskutoff DJ; Isackson PJ; Cunningham DD
J Neurochem; 1991 Jan; 56(1):234-42. PubMed ID: 1987320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
